Based on the findings of a 2017 report by Ahlin and colleagues, it was demonstrated that only in patients with ER + breast cancer (and not in those with ER- disease), the elevated expression of cyclin D1 is correlated with increased cell proliferation and a three-fold higher death risk (Ahlin et al. 2017). This evidence concerns the gene CCND1 and breast carcinoma.